PANBIO
Live / Registered — Registered (as of 08 Jun 2021)
What this means for you
Registered since 08 Jun 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79285587
- Registration number
- 6375117
- Mark type
- Stylized text
- Filed
- 08 Apr 2020
- Published for opposition
- 23 Mar 2021
- Registered
- 08 Jun 2021
- Attorney of record
- Michele H. Bowman
Goods and services
- Class 001 — Chemicals: Control preparations for in vitro diagnostic testing, screening, confirmation and analysis, namely, diagnostic preparations for scientific or research use; diagnostic reagents and chemical reagents for laboratory or research purposes; chemical reagents, namely, solutions used in diagnostic test kits for laboratory or research purposes; chemically-treated nonmedical test strips for laboratory or research purposes for testing for respiratory, community acquired, hospital acquired, sexual health, gastro-enteric, vector borne, blood borne pathogen, and tropical disease infections; diagnostic test kits comprised of reagents for use in diagnostic tests for laboratory or research use; diagnostic preparations for laboratory or research use; diagnostic test kits comprising reagents and assays for laboratory or research use; in vitro diagnostic tests, namely, chemical reagents and assays for testing for respiratory, community acquired, hospital acquired, sexual health, gastro-enteric, vector borne, blood borne pathogen, and tropical disease infections for laboratory or research use, other than for medical or veterinary use; in vitro immunochromatographic tests, namely, chemical reagents and assays for testing for respiratory, community acquired, hospital acquired, sexual health, gastro-enteric, vector borne, blood borne pathogen, and tropical disease infections for laboratory or research use, other than for medical or veterinary use
- Class 005 — Pharmaceuticals: Diagnostic kits comprising medical diagnostic bioreagents for testing blood, bodily fluid, nasal samples, oral samples and tissue for use in the detection, identification, confirmation, and monitoring of respiratory, community acquired, hospital acquired, sexual health, gastro-enteric, vector borne, blood borne pathogen, and tropical disease infections; medical diagnostic test kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; medical diagnostic test strips for testing blood, human serum, plasma, bodily fluid, nasal swab specimens, nasopharyngeal swab specimens, oral specimens, oropharyngeal swab specimens, and tissue for use in the detection, identification, confirmation, and monitoring of respiratory, community acquired, hospital acquired, sexual health, gastro-enteric, vector borne, blood borne pathogen, and tropical disease infections; medical diagnostic reagents; diagnostic preparations for medical purposes; testing preparations for medical use, namely, diagnostic preparations; diagnostic tests for medical use, namely, medical diagnostic test media in the form of strips, cassettes, cartridges, and cards for the detection, identification, confirmation, and monitoring of respiratory, community acquired, hospital acquired, sexual health, gastro-enteric, vector borne, blood borne pathogen, and tropical disease infections; medical diagnostic assays for testing of body fluids, blood, human serum, plasma, nasal swab specimens, nasopharyngeal swab specimens, oral specimens, oropharyngeal swab specimens, and tissue; in vitro medical diagnostic tests, namely, medical diagnostic test media in the form of strips, cassettes, cartridges, and cards for the detection, identification, confirmation, and monitoring of respiratory, community acquired, hospital acquired, sexual health, gastro-enteric, vector borne, blood borne pathogen, and tropical disease infections; in vitro medical diagnostic assays for testing of body fluids, blood, human serum, plasma, nasal swab specimens, nasopharyngeal swab specimens, oral specimens, oropharyngeal swab specimens, and tissue; in vitro medical diagnostic test kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; in vitro medical diagnostic test strips for use in the field of infectious disease; in vitro medical diagnostic reagents; in vitro immunochromatographic tests for medical use, namely, medical diagnostic reagents and assays for testing of body fluids, blood, human serum, plasma, nasal swab specimens, nasopharyngeal swab specimens, oral specimens, oropharyngeal swab specimens, and tissue; medical diagnostics tests for the detection, diagnosis, screening, and confirmation of infections, namely, medical diagnostic reagents and assays for testing of body fluids, blood, human serum, plasma, nasal swab specimens, nasopharyngeal swab specimens, oral specimens, oropharyngeal swab specimens, and tissue
Owner
Prior registrations
Prosecution history
- 03 Jan 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 05 Jan 2024 — NEW REPRESENTATIVE AT IB RECEIVED
- 15 Nov 2021 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 28 Sept 2021 — GENERIC MADRID TRANSACTION SENT TO IB
- 28 Sept 2021 — GENERIC MADRID TRANSACTION CREATED
- 08 Sept 2021 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 08 Jun 2021 — REGISTERED-PRINCIPAL REGISTER
- 23 Mar 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Mar 2021 — PUBLISHED FOR OPPOSITION
- 21 Mar 2021 — NOTIFICATION PROCESSED BY IB
- 03 Mar 2021 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 03 Mar 2021 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 03 Mar 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 Feb 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Feb 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED